十大电竞直播ios下载官方

  • Previous Nav

  • Net Change on 09-09-2022

  • 十大电竞(广州)最新版登录正规 Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIPPON INDIA PHARMA FUND - IDCW Option 0.02 5.25 -10.91 24.31 17.27 19.82
S&P BSE Health Care - TRI -0.22 5.25 -12.06 21.96 12.77 13.71
S&P BSE SENSEX - TRI 1.69 8.53 3.85 18.53 14.86 13.55

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 -10.91 24.31 17.27 1.98 4,587.75
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 -7.69 24.45 12.49 2.18 1,675.44
UTI Healthcare Fund - Regular Plan - IDCW Aug 25, 1999 -12.04 23.07 13.05 2.39 713.11
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 -9.23 22.42 15.33 2.50 519.10
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum capital withdrawal option Dec 28, 2015 -9.23 22.42 15.33 2.50 519.10

Fund Holdings as on 31-August-2022

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Dr. Reddy's Laboratories Limited

  • Lupin Limited

  • Torrent Pharmaceuticals Limited

  • Divi's Laboratories Limited

  • Narayana Hrudayalaya Limited

  • Abbott India Limited

  • Aurobindo Pharma Limited

  • Fortis Healthcare Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Gland Pharma Limited

  • Sanofi India Limited

  • Apollo Hospitals Enterprise Limited

  • Zydus Lifesciences Limited

  • Pfizer Limited

  • Thyrocare Technologies Limited

  • Ajanta Pharma Limited

  • Alkem Laboratories Limited

  • Vijaya Diagnostic Centre Limited

  • Indoco Remedies Limited

  • IPCA Laboratories Limited

  • Rainbow Childrens Medicare Limited

  • Orchid Pharma Limited

  • Tarsons Products Limited

  • Triparty Repo

  • GlaxoSmithKline Pharmaceuticals Limited

  • Jubilant Pharmova Limited

  • Healthcare Global Enterprises Limited

  • Cash Margin - CCIL

  • Net Current Assets

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Plastic Products

  • Miscellaneous

View More

Fund Manager

Most Recent Dividend

  • 28/02/2022

  • 01/03/2021

  • 02/03/2020

  • 05/03/2019

  • 05/03/2018

  • 06/03/2017

  • 08/03/2016

  • 02/02/2015

  • 17/02/2014

  • 14/01/2013

  • 16/03/2012

  • 28/02/2011

  • 31/08/2009

  • 24/03/2008

  • 22/02/2007

  • 19/12/2005

  • Cash

  • Equity

View More

About Nippon India Pharma Fund

Scheme Analysis

Nippon India Pharma Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Nippon India Mutual Fund . It was launched on 05-Jun-2004 and currently has an AUM of ₹4,587.75 crore. Nippon India Pharma Fund is benchmarked against S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.

The NAV of Nippon India Pharma Fund ended down ₹-0.04 (-0.05%) yesterday to ₹77.45 .

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Nippon India Pharma Fund is managed by Sailesh Raj Bhan and Kinjal Desai.

Fund House Contact

4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

022-68087000
022-68087097
英雄联盟竞猜赛事在线永久 fifa电竞(长春)手游外围1.4.10 gtv电竞比赛数据 大圣电竞数据APP v2.3 esg电竞比分详情 lpl电竞比赛排名官网